$SMR

NuScale Power faces securities fraud lawsuit over failing to disclose risks associated with a $495 million ENTRA1 deal. Stock fell 12.4% after November disclosure.

NuScale Power begins first commercial SMR deployment in Romania with NRC-approved design, positioning itself in a $10 trillion nuclear energy market amid growing low-carbon energy demand.

YieldMax launches MINY ETF using options strategies to generate income from strategic metals and mining companies, starting February 27, 2026.

NuScale Power faces shareholder lawsuit alleging false statements about ENTRA1 partnership qualifications and undisclosed risks. Stock dropped 12% after revealing $495M payment and $532M quarterly loss.

NuScale Power secured U.S. regulatory approval for SMR designs and signed a $6-7 billion Romania contract, positioning it for growth despite current unprofitability.

NuScale Power faces securities lawsuit for allegedly failing to disclose material risks tied to its ENTRA1 partnership, which resulted in a $495 million payment obligation and significant stock decline.

NuScale offers debt-free stability but delayed revenues (2029+), while Plug Power generates current revenue but faces unprofitability and cash burn. Both are high-risk clean energy plays.

NuScale Power faces securities fraud lawsuit over alleged misrepresentations about its ENTRA1 Energy partnership. Stock fell 70% after November 2025 disclosures of $495M payment and $532M loss.

NuScale Power stock plummeted 77% amid market concerns about small reactor viability, despite securing regulatory approval for a Romania project expected online in 2033.

NuScale secures TVA contract for 6GW SMR capacity and reports $8.2M Q3 revenue, positioning it ahead of rival Oklo in commercialization timeline.

Barclays slashed NuScale Power's price target 67% to $15, joining Goldman Sachs in downgrading the small modular reactor developer amid concerns about commercialization viability.

Bernstein Liebhard files class action lawsuit against Zynex for alleged overbilling scheme artificially inflating revenue from 2018-2023. Affected shareholders urged to evaluate legal options.

Law firm Bernstein Liebhard files class action lawsuit against Corcept Therapeutics for alleged material misrepresentations about relacorilant drug clinical evidence.

NuScale and Oklo compete in SMRs with different strategies: NuScale secured regulatory approval for faster deployment, while Oklo pursues vertical integration through fuel technology acquisition.

NuScale Power shares fell 12% after revealing its $495M ENTRA1 partner was misrepresented—a three-person startup, not experienced firm. Securities fraud lawsuit filed.

Rosen Law Firm investigates Phoenix Education Partners for allegedly misleading investors about a data breach affecting 3.5 million people. Shareholders encouraged to seek legal counsel.

NuScale Power, the only U.S.-approved small modular reactor developer, faces profitability challenges despite promising nuclear technology and surging data center demand, but lacks firm customer contracts.

NuScale Power faces class action lawsuit alleging it made false statements about ENTRA1 partnership, claiming the partner lacked nuclear experience despite managing hundreds of millions in commercialization funds.

NuScale Power faces class action lawsuit alleging false statements about partner ENTRA1's qualifications. Stock declined 12% after disclosing $495M payment and $532M quarterly loss.

Class action lawsuit filed against NuScale Power for allegedly misrepresenting nuclear partner ENTRA1's experience. Investors claim material misstatements about partner's qualifications were not disclosed timely.